Further studies on the mechanism underlying the inhibitory effect on prostate cancer found that miR-99b-5p could bind to its downstream target insulin-like growth factor 1 receptor (IGF1R), downregulate it, and inhibit the progression of prostate cancer. Here, IGF1R is linked to prostate cancer.